- Raised $2M Undisclosed Round led by BioStar Capital, Jul 2015
- Raised grant, May 2017
About
NewPace is an Israeli medical technology company based in Caesarea that develops wearable and implantable defibrillators. The company offers solutions that include wearable and implantable defibrillation devices, aiming to provide short-term and long-term protection for patients with ventricular fibrillation and sudden cardiac arrest. Their flagship product, the ISSD, is described as the world's first rechargeable implantable defibrillator. NewPace also develops a wearable defibrillator belt (DBelt) for at-risk patients. NewPace is the only company with both wearable and implantable defibrillator solutions. Both the DBelt and ISSD are development-stage products and are not yet approved for commercial use. NewPace develops a flexible and subcutaneous implantable cardioverter defibrillator (ICD) with no leads within the heart, a wireless rechargeable battery, and Bluetooth communication. The device is implanted subcutaneously without the need for fluoroscopy and communicates with a smartphone via Bluetooth. The string-shaped defibrillator requires one hour per year for wireless recharge.
Funding history · 2 rounds · $2.0M total
Headcount over time
Q&A
- What is Newpace's primary product?
- Newpace develops a flexible and subcutaneous implantable cardioverter defibrillator (ICD) that does not require leads within the heart. It features a wireless rechargeable battery and Bluetooth communication.
- How does Newpace's defibrillator differ from standard ICDs?
- The Newpace defibrillator is implanted subcutaneously without leads in the heart, eliminating the need for fluoroscopy. It is rechargeable, requires one hour per year for wireless recharging, and communicates via Bluetooth with a smartphone for monitoring.
- When was Newpace founded?
- Newpace was founded in October 2012.
- What is the total amount of funding Newpace has raised?
- Newpace has raised a total of $2,000,000.
- Which investors participated in Newpace's August 2015 funding round?
- In August 2015, Newpace received funding from Net Capital Ventures and BioStar Capital.
- Has Newpace received any grants?
- Yes, Newpace received a grant from EU Horizon 2020 in June 2017.
- Who is a co-founder and executive at Newpace?
- Avi Broder is a Co-founder, CFO & VP BD at Newpace.
- What is Newpace's primary sector?
- Newpace's primary sector is Health Tech & Life Sciences.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | newpacemedical.com |
|---|---|
| linkedin.com/company/28123492 |
Identifiers & details
| Legal name | NewPace Ltd. |
|---|---|
| Founded | 2012-10 |
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 17 |
|---|
Web history (Wayback)
| Domain | newpacemedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514835214 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2012-10-31 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 2 — charge (2) |
| Registered address | גרניט 13 קיסריה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-06 | סילוק שעבוד |
| 2025-11-06 | סילוק שעבוד |